<article><p>Shanghai-based <a href="https://www.dealstreetasia.com/?s=Abbisko%20Therapeutics"><strong>Abbisko Therapeutics</strong></a> has closed a $42-million Series B funding round led by venture capital firm <a href="https://www.dealstreetasia.com/?s=Qiming%20Venture Partners"><strong>Qiming Venture Partners</strong></a>.</p></article>

The round was joined by CICC Capital, Loyal Valley Capital, existing investors Lilly Asia Ventures and TF Capital Investments, and an undisclosed sovereign wealth fund.

China's Qiming Ventures leads $42m funding for Abbisko Therapeutics

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Read more from Greater China

China’s SparkEdge Capital hits first close of second RMB fund

Chinese ride-hailing company Didi Global reports 8.5% revenue rise in Q1

China's Qiming Ventures leads $42m funding for Abbisko Therapeutics

Register now to enjoy 3 free articles per month, or log in to continue reading.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Read more from Greater China

China’s SparkEdge Capital hits first close of second RMB fund

Chinese ride-hailing company Didi Global reports 8.5% revenue rise in Q1

Register now to enjoy 3 free articles per month,
or log in to continue reading.